InvestorsHub Logo

GD

08/13/20 1:19 PM

#32825 RE: Fosco1 #32823

I post my speculation on stockwits that it is possible Geert
may try to PR the success of the trial without any data first
next week and the complete data is presented at ESMO as a
late-break presentation, unprecedented for a small biotech
to do this, but CEO Geert has proved to me he is very
unconventional. We do not have to wait long, next week is
going to prove my speculation right or wrong. By the way,
do you know who is Principal Investigator for IT-MATTERS?
CVM do not list it here:

https://www.clinicaltrials.gov/ct2/show/NCT01265849?term=Multikine&draw=2&rank=3

sab63090

08/13/20 1:51 PM

#32829 RE: Fosco1 #32823

@Fosco and @GD

Thank you both for your thoughts on this and Lightrock, too....

I am totally in the dark, but feel you have provided interesting perspectives on how this will possibly shake out.

If other companies have not followed the protocol that Geert is now taking I am thinking it might be to put those 9.7 million short shares on the fence, even though they might be people long stock, long warrants and writing covered calls awaiting/expecting a price break to cover.

As GD mentioned, he is expecting some news next week possibly.

I am watching price and especially the volume.